- Home
- KMDA vs CPS Comparison
KMDA vs CPS Comparison
Compare KMDA & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- CPS
- Stock Information
- Founded
- KMDA 1990
- CPS 1960
- Country
- KMDA Israel
- CPS United States
- Employees
- KMDA N/A
- CPS N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- KMDA Health Care
- CPS Consumer Discretionary
- Exchange
- KMDA Nasdaq
- CPS Nasdaq
- Market Cap
- KMDA 410.6M
- CPS 462.2M
- IPO Year
- KMDA N/A
- CPS N/A
- Fundamental
- Price
- KMDA $7.33
- CPS $38.61
- Analyst Decision
- KMDA Strong Buy
- CPS Hold
- Analyst Count
- KMDA 2
- CPS 1
- Target Price
- KMDA $13.00
- CPS $12.00
- AVG Volume (30 Days)
- KMDA 51.8K
- CPS 225.5K
- Earning Date
- KMDA 08-13-2025
- CPS 10-30-2025
- Dividend Yield
- KMDA 2.80%
- CPS N/A
- EPS Growth
- KMDA 27.97
- CPS N/A
- EPS
- KMDA 0.32
- CPS 1.65
- Revenue
- KMDA $169,517,000.00
- CPS $2,719,148,000.00
- Revenue This Year
- KMDA $14.49
- CPS $2.46
- Revenue Next Year
- KMDA $10.12
- CPS $3.29
- P/E Ratio
- KMDA $21.69
- CPS $23.32
- Revenue Growth
- KMDA 9.67
- CPS N/A
- 52 Week Low
- KMDA $5.17
- CPS $10.38
- 52 Week High
- KMDA $9.16
- CPS $39.79
- Technical
- Relative Strength Index (RSI)
- KMDA 54.83
- CPS 81.19
- Support Level
- KMDA $6.90
- CPS $37.83
- Resistance Level
- KMDA $7.43
- CPS $39.79
- Average True Range (ATR)
- KMDA 0.19
- CPS 1.75
- MACD
- KMDA 0.03
- CPS 0.36
- Stochastic Oscillator
- KMDA 80.19
- CPS 89.75
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.